Pharmaceutical Technology's
Implementing On-Dose Anticounterfeiting Technologies for Solid-Dose Drug Products

Thank you for registering for Pharmaceutical Technology's October 14 Implementing On-Dose Anticounterfeiting Technologies for Solid-Dose Drug Products Webcast.

 

In this Executive Summary, learn about regulatory and manufacturing considerations when implementing on-dose verification technologies for branded solid oral dosage form drugs and how this technology can provide customized business intelligence at the dosage level without relying exclusively on product packaging. Industry experts will review FDA’s guidance on physical-chemical identifiers in solid dosage drug forms for the purpose of product security and will share real-world testing and piloting completed in manufacturing environments.

Executive Summary

Access the Executive Summary Now

 

View Pharmaceutical Technology's October 14 Implementing On-Dose Anticounterfeiting Technologies for Solid-Dose Drug Products Webcast again

Presented by
Sponsored by
Ophthalmology Times